
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Natural killer cells in antitumour adoptive cell immunotherapy
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 482
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 482
Showing 1-25 of 482 citing articles:
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
David Marín, Ye Li, Rafet Başar, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 772-784
Open Access | Times Cited: 164
David Marín, Ye Li, Rafet Başar, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 772-784
Open Access | Times Cited: 164
Natural killer cell therapies
Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 727-736
Closed Access | Times Cited: 151
Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 727-736
Closed Access | Times Cited: 151
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
Guang Lei, Li Zhuang, Boyi Gan
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 513-534
Open Access | Times Cited: 116
Guang Lei, Li Zhuang, Boyi Gan
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 513-534
Open Access | Times Cited: 116
Allogeneic natural killer cell therapy
Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger
Blood (2022) Vol. 141, Iss. 8, pp. 856-868
Open Access | Times Cited: 114
Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger
Blood (2022) Vol. 141, Iss. 8, pp. 856-868
Open Access | Times Cited: 114
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Nina Lamers-Kok, Denise Panella, Anna‐Maria Georgoudaki, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 102
Nina Lamers-Kok, Denise Panella, Anna‐Maria Georgoudaki, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 102
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 98
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 98
Exosomal circRNA: emerging insights into cancer progression and clinical application potential
Fan Zhang, Jiajia Jiang, Hui Qian, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 98
Fan Zhang, Jiajia Jiang, Hui Qian, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 98
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 68
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 68
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Forks in the road for CAR T and CAR NK cell cancer therapies
Oula K. Dagher, Avery D. Posey
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1994-2007
Closed Access | Times Cited: 57
Oula K. Dagher, Avery D. Posey
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1994-2007
Closed Access | Times Cited: 57
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
Yanlin Yu
Cancers (2023) Vol. 15, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 53
Yanlin Yu
Cancers (2023) Vol. 15, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 53
Engineered Living Materials for Advanced Diseases Therapy
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 53
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 53
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 52
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 52
The effect of physical exercise on anticancer immunity
Carmen Fiuza‐Luces, Pedro L. Valenzuela, Beatriz G. Gálvez, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 282-293
Open Access | Times Cited: 51
Carmen Fiuza‐Luces, Pedro L. Valenzuela, Beatriz G. Gálvez, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 282-293
Open Access | Times Cited: 51
L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis
Jianxin Cui, Xian-Hui Xu, Tao He, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 50
Jianxin Cui, Xian-Hui Xu, Tao He, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 50
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
Michael C. Burger, Marie-Thérèse Forster, A Romański, et al.
Neuro-Oncology (2023) Vol. 25, Iss. 11, pp. 2058-2071
Open Access | Times Cited: 50
Michael C. Burger, Marie-Thérèse Forster, A Romański, et al.
Neuro-Oncology (2023) Vol. 25, Iss. 11, pp. 2058-2071
Open Access | Times Cited: 50
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 48
Roel Polak, Elisa Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 48
Immature natural killer cells promote progression of triple-negative breast cancer
Gatha Thacker, Samantha Henry, Ajeya Nandi, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 686
Closed Access | Times Cited: 44
Gatha Thacker, Samantha Henry, Ajeya Nandi, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 686
Closed Access | Times Cited: 44
Recent Advances in CAR-Based Solid Tumor Immunotherapy
Min Hwa Shin, Eunha Oh, Yun Jeong Kim, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1606-1606
Open Access | Times Cited: 44
Min Hwa Shin, Eunha Oh, Yun Jeong Kim, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1606-1606
Open Access | Times Cited: 44
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 34
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 34
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 32
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 32